Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition-Reference-Cited by-同舟云学术

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition

Published:2006-04-13 Issue:11 Volume:106 Page:2318-2326
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kriege Mieke,Brekelmans Cecile T. M.,Boetes Carla,Muller Sara H.,Zonderland Harmine M.,Obdeijn Inge Marie,Manoliu Radu A.,Kok Theo,Rutgers Emiel J. T.,de Koning Harry J.,Klijn Jan G. M.,

Funder

Dutch Health Insurance Council

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation;Meijers-Heijboer;Lancet.,2000

2. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers;Scheuer;J.Clin.Oncol.,2002

3. Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics;Vasen;Eur J Cancer.,1998

4. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk;Brekelmans;J.Clin.Oncol.,2001

5. MRI screening for breast cancer in women with a familial or genetic predisposition;Kriege;Imaging Decis.,2005

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening in Women With BRCA Mutations Revisited;Journal of Breast Imaging;2024-01-01

2. Comparative Analysis of Diagnostic Performance of Automatic Breast Ultrasound, Full-Field Digital Mammography and Contrast-Enhanced Mammography in Relation to Breast Composition;Biomedicines;2023-12-06

3. Advances in PET/CT Imaging for Breast Cancer;Journal of Clinical Medicine;2023-07-07

4. SEOM clinical guideline on heritable TP53-related cancer syndrome (2022);Clinical and Translational Oncology;2023-05-03

5. Breast cancer: an up‐to‐date review and future perspectives;Cancer Communications;2022-09-08